307 related articles for article (PubMed ID: 21806599)
1. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).
Suen JY; Barry GD; Lohman RJ; Halili MA; Cotterell AJ; Le GT; Fairlie DP
Br J Pharmacol; 2012 Mar; 165(5):1413-23. PubMed ID: 21806599
[TBL] [Abstract][Full Text] [Related]
2. Novel agonists and antagonists for human protease activated receptor 2.
Barry GD; Suen JY; Le GT; Cotterell A; Reid RC; Fairlie DP
J Med Chem; 2010 Oct; 53(20):7428-40. PubMed ID: 20873792
[TBL] [Abstract][Full Text] [Related]
3. Pathway-selective antagonism of proteinase activated receptor 2.
Suen JY; Cotterell A; Lohman RJ; Lim J; Han A; Yau MK; Liu L; Cooper MA; Vesey DA; Fairlie DP
Br J Pharmacol; 2014 Sep; 171(17):4112-24. PubMed ID: 24821440
[TBL] [Abstract][Full Text] [Related]
4. An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats.
Lohman RJ; Cotterell AJ; Barry GD; Liu L; Suen JY; Vesey DA; Fairlie DP
FASEB J; 2012 Jul; 26(7):2877-87. PubMed ID: 22467762
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of protease-activated receptor 2 protects against experimental colitis.
Lohman RJ; Cotterell AJ; Suen J; Liu L; Do AT; Vesey DA; Fairlie DP
J Pharmacol Exp Ther; 2012 Feb; 340(2):256-65. PubMed ID: 22028393
[TBL] [Abstract][Full Text] [Related]
6. Mapping transmembrane residues of proteinase activated receptor 2 (PAR
Suen JY; Adams MN; Lim J; Madala PK; Xu W; Cotterell AJ; He Y; Yau MK; Hooper JD; Fairlie DP
Pharmacol Res; 2017 Mar; 117():328-342. PubMed ID: 27993717
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2.
Lieu T; Savage E; Zhao P; Edgington-Mitchell L; Barlow N; Bron R; Poole DP; McLean P; Lohman RJ; Fairlie DP; Bunnett NW
Br J Pharmacol; 2016 Sep; 173(18):2752-65. PubMed ID: 27423137
[TBL] [Abstract][Full Text] [Related]
8. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
Huang SC
Regul Pept; 2014 Feb; 189():46-50. PubMed ID: 24631471
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
[TBL] [Abstract][Full Text] [Related]
10. Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants.
Cattaruzza F; Amadesi S; Carlsson JF; Murphy JE; Lyo V; Kirkwood K; Cottrell GS; Bogyo M; Knecht W; Bunnett NW
Br J Pharmacol; 2014 Aug; 171(16):3814-26. PubMed ID: 24749982
[TBL] [Abstract][Full Text] [Related]
11. Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.
Kanke T; Ishiwata H; Kabeya M; Saka M; Doi T; Hattori Y; Kawabata A; Plevin R
Br J Pharmacol; 2005 May; 145(2):255-63. PubMed ID: 15765104
[TBL] [Abstract][Full Text] [Related]
12. Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity.
Yau MK; Liu L; Lim J; Lohman RJ; Cotterell AJ; Suen JY; Vesey DA; Reid RC; Fairlie DP
Bioorg Med Chem Lett; 2016 Feb; 26(3):986-991. PubMed ID: 26725028
[TBL] [Abstract][Full Text] [Related]
13. PAR2 Modulators Derived from GB88.
Yau MK; Liu L; Suen JY; Lim J; Lohman RJ; Jiang Y; Cotterell AJ; Barry GD; Mak JY; Vesey DA; Reid RC; Fairlie DP
ACS Med Chem Lett; 2016 Dec; 7(12):1179-1184. PubMed ID: 27994760
[TBL] [Abstract][Full Text] [Related]
14. Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport.
Vergnolle N; Macnaughton WK; Al-Ani B; Saifeddine M; Wallace JL; Hollenberg MD
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7766-71. PubMed ID: 9636225
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of Protease Activated Receptor-2 by GB88 Reduces Inflammation Triggered by Protease Allergen Tyr-p3.
Wang YJ; Yu SJ; Tsai JJ; Yu CH; Liao EC
Front Immunol; 2021; 12():557433. PubMed ID: 34566947
[TBL] [Abstract][Full Text] [Related]
16. The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2).
Dale CS; Cenac N; Britto LR; Juliano MA; Juliano L; Vergnolle N; Giorgi R
Br J Pharmacol; 2006 Oct; 149(4):374-84. PubMed ID: 16967049
[TBL] [Abstract][Full Text] [Related]
17. A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists.
Compton SJ; Cairns JA; Palmer KJ; Al-Ani B; Hollenberg MD; Walls AF
J Biol Chem; 2000 Dec; 275(50):39207-12. PubMed ID: 10995771
[TBL] [Abstract][Full Text] [Related]
18. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells.
Jiang Y; Yau MK; Lim J; Wu KC; Xu W; Suen JY; Fairlie DP
J Pharmacol Exp Ther; 2018 Feb; 364(2):246-257. PubMed ID: 29263243
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
[TBL] [Abstract][Full Text] [Related]
20. Structures of peptide agonists for human protease activated receptor 2.
Stoermer MJ; Flanagan B; Beyer RL; Madala PK; Fairlie DP
Bioorg Med Chem Lett; 2012 Jan; 22(2):916-9. PubMed ID: 22209488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
